Oramed Pharmaceuticals Aktie
1,91
EUR
+0,10
EUR
+5,33
%
2,27
USD
+0,12
USD
+5,58
%
Werbung
Oramed Pharmaceuticals Aktie Analyse
| 11.12.17 | Oramed Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 26.05.16 | Oramed Pharmaceuticals Outperform | FBR Capital | |
| 01.12.15 | Oramed Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 19.11.15 | Oramed Pharmaceuticals Outperform | FBR Capital | |
| 13.04.15 | Oramed Pharmaceuticals Buy | MLV Capital | |
| 19.08.08 | Oramed Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung